MyAverix Finance
US · Healthcare
Mesoblast Ltd (MESO)
Biotechnology
Mesoblast Ltd (MESO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MESO
Mesoblast Ltd (MESO) — FAQ
What is MESO's P/E ratio?
The price-to-earnings (P/E) ratio for Mesoblast Ltd (MESO) is 18.00 (data as of 2026-03-24).
Does Mesoblast Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Mesoblast Ltd (MESO). Check the MyAverix Finance app for the latest dividend data.
What sector is Mesoblast Ltd in?
Mesoblast Ltd (MESO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MESO listed on?
MESO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.